Table 5.
Without NC | Prevalent NC | Incident NC | P value | |
---|---|---|---|---|
All PH type | 156 | 57 | 22 | |
eGFR at diagnosis | 74.0 (57.6, 97.5) | 68.2 (50.0, 87.4) | 69.8 (56.7, 91.7) | 0.24 |
eGFR at last follow-upa | 79.8 (55.6, 104.4) | 69.1 (48.7, 91.9) | 62.6 (30.4, 89.5) | 0.03 |
eGFR decline rate,/yr | −0.4 (−1.9, 3.0) | −0.4 (−2.3, 1.9) | −1.2 (−3.8, 0.02) | 0.08 |
ESKD | 21.2% | 24.6% | 45.5% | 0.04 |
PH1 subgroup | 101 | 51 | 18 | |
eGFR at diagnosis | 68.9 (51.8, 89.0) | 64.2 (46.8, 85.3) | 69.8 (56.7, 90.2) | 0.56 |
eGFR at last follow-upa | 67.3 (44.2, 86.9) | 64.2 (34.5, 91.7) | 54.9 (28.5, 85.3) | 0.33 |
eGFR decline rata,/yr | −0.3 (−2.5, 1.8) | −0.2 (−2.1, 2.8) | −1.5 (−3.8, −0.1) | 0.16 |
ESKD | 32.7% | 27.5% | 50.0% | 0.21 |
Patients who had ESKD before first image were excluded in the analysis. All eGFR values were expressed as median (interquartile range).
Data were cut at eGFR of 20 ml/min/1.73m2